Latest News - CRSTodayEurope

Friday, May 26, 2017 | Medical Studies

Diabetic Macular Edema Rates Increase After Cataract Surgery

The rates of treatment-requiring diabetic macular edema (DME) increase sharply in the year after cataract surgery, according to new findings from the U.K. Cataract surgery leads to increased levels of…

Read the full story

Friday, May 26, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie Pharmaceuticals announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole bookr…

Read the full story

Thursday, May 25, 2017 | Medical Studies

Warby Parker Wants to Check Your Eyeglass Prescription with an App, But Some are Calling the Approach 'Dangerous'

Warby Parker, the $1 billion+ eyeglasses retailer, just launched an app that could make it easier to check your eyeglass prescription. The app, called Prescription Check, is meant to help people check…

Read the full story

Thursday, May 25, 2017 | Conferences

Housing, Meeting Registration Are Now Open for 2018 ASCRS Annual Meeting in Washington, D.C.

The ASCRS•ASOA Symposium & Congress is headed to Washington, D.C. during cherry blossom season in 2018 -- and housing and registration are now open. Are you planning to attend? If so, you&r…

Read the full story

Wednesday, May 24, 2017 | Clinical Trials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for Roclatan

Aerie Pharmaceuticals reported the successful primary efficacy results of the company’s 90-day, phase 3 Mercury 2 registration trial for its fixed-dose combination product candidate, Roclatan. T…

Read the full story

Tuesday, May 23, 2017 | Acquisitions/Mergers

ClearSight Announces Sale of Parent Company, Sharklet Technologies

ClearSight LLC has announcd the acquisition of its parent company Sharklet Technologies by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight LLC was co-founded by Drs. Kevin…

Read the full story

Tuesday, May 23, 2017 | Medical Studies, Glaukos Corporation

Study Reveals Potential Cost Efficiency of Using Two Glaukos iStent Trabecular Micro-Bypass Stents to Treat Elevated IOP

Glaukos announced that an analysis published in the Journal of Medical Economics evaluating various options for treating elevated IOP in open-angle glaucoma patients showed that two iStent Trabecular …

Read the full story

Tuesday, May 23, 2017 | Clinical Trials

Dompé Receives Positive CHMP Opinion in Europe For Oxervate for the Treatment of Adult Patients with Moderate or Severe Neurotrophic Keratitis

Dompé has announced that the Committee for Human Medicinal Products of the European Medicines Agency (EMA) has released a positive opinion, recommending the marketing authorization for Oxervate…

Read the full story

Monday, May 22, 2017 | FDA Approval/Clearance, Genentech

FDA Approves Genentech’s Actemra for Giant Cell Arteritis

Genentech announced that the FDA has approved Actemra (tocilizumab) subcutaneous injection for the treatment of giant cell arteritis (GCA), a chronic and severe autoimmune condition. Actemra is the fi…

Read the full story

Monday, May 22, 2017 | Earnings & Financials, Eyegate Pharmaceuticals

EyeGate Receives Milestone Payment from Valeant for EGP-437 for Postoperative Ocular Inflammation and Pain

EyeGate Pharmaceuticals announced that it has received its first development milestone from a subsidiary of Valeant under the company's license agreement with Valeant, pursuant to which EyeGate …

Read the full story

Monday, May 22, 2017 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE

NovaBay Pharmaceuticals announced receipt of a letter from NYSE MKT LLC on May 16, 2017, stating that it is not in compliance with the continued listing standards (requiring stockholders’ equity…

Read the full story

Monday, May 22, 2017 | Medical Studies

High Vitamin K1 Intake Linked to Reduced Cataract Risk

María L. Camacho-Barcia, RD, from the University Hospital of Sant Joan de Reus in Spain, and colleagues examined the correlation between dietary vitamin K1 intake and the risk of incident catar…

Read the full story

Monday, May 22, 2017 | Medical Studies

Vision Impairment Among U.S. Preschoolers a Growing Problem

A growing number of U.S. children may develop vision problems before they reach kindergarten, according to a study that suggests eye screenings will become increasingly important for the preschool set…

Read the full story

Friday, May 19, 2017 | Conferences

The 2nd Annual Ophthalmic Drug Development Summit to Bring Together Leading Pharma, Biotech, and Industry Stakeholders

Incorporating a balance of insights into innovative therapies and solutions to existing challenges, the 2nd Annual Ophthalmic Drug Development Summit will bring together leading pharma, biotech, and i…

Read the full story

Friday, May 19, 2017 |

SALT Spotlight: Ackman Explains His Valeant 'Mistake'

By now, we all know that Pershing Square's William Ackman made a big mistake with Valeant Pharmaceuticals International (VRX), which he bought near its highs, and recently sold. Today, at the SALT…

Read the full story
Load More